Table 1.
Baseline characteristics and outcomes among 155 women with 179 β-hCG confirmed pregnancies enrolled in the Environment and Reproductive Health Study (EARTH) between 2004 and 2015.
Characteristic | Total Cohort (N=155) N (%) |
---|---|
Age at study entry (years) | |
Mean (SD) | 34.9 (3.6) |
Min-Max | 27–42 |
Age > 35 | 64 (41%) |
BMI (kg/m2) | |
Mean (SD) | 23.6 (4.0) |
Min-Max | 16–37 |
Overweight or obese (≥25) | 46 (30%) |
Educationa | |
< College graduate | 8 (5%) |
College graduate | 52 (34%) |
Graduate degree | 85 (55%) |
Smoking | |
Never smoked | 120 (77%) |
Ever smoked | 35 (23%) |
Race | |
Caucasian | 135(87%) |
Black/African American | 2 (1%) |
Asian | 14 (9%) |
Other | 4 (3%) |
Nulligravida | 100 (65%) |
Nullipara | 134 (87%) |
Primary SART diagnosis | |
Female factor | 44 (28%) |
Diminished ovarian reserve | 7 (4%) |
Ovulation disorders | 17 (11%) |
Endometriosis | 8 (5%) |
Uterine disorders | 2 (1%) |
Tubal factor | 10 (6%) |
Male factor | 60 (39%) |
Unexplained | 51 (33%) |
FSH Day 3 in IU/L | |
Mean (SD) | 6.9 (2.1) |
Pregnancy Loss Outcomesb,c,d | |
Biochemical Loss | 21 (12%) |
Loss <20 weeks | 56 (31%) |
Abbreviations: Body Mass Index (BMI); Standard Deviation (SD); Minimum (Min); Maximum (Max); Follicle Stimulating Hormone (FSH, measured in serum on day 3); Society for Assisted Reproductive Technology (SART) primary diagnosis at study entry.
Unknown/missing education values: n=10.
Pregnancy was defined as two or more serum β-hCG levels >= 6 mIU/mL. Biochemical pregnancy loss was defined as the demise of a non-visualized β-hCG confirmed pregnancy. Pregnancy loss <20 weeks gestation was defined as the loss of any pregnancy (including biochemical losses) of less than 20 weeks gestation (<=139 days).
Proportion of pregnancy loss outcomes in total number of pregnancies (n/179).
Biochemical pregnancy losses by quartile of the sum of organophosphate flame retardant concentrations (ΣPFR): 4/44 (9%); 6/45 (13%); 4/45 (9%); 7/45 (16%); Total losses by quartile of ΣPFR: 12/44 (27%); 17/45 (38%); 13/45 (29%); 14/45 (31%).